Related by context. Frequent words. (Click for all words.) 61 Plenaxis R 60 ZALBIN 60 Therapeutic Products 60 Marketing Authorization 59 FIRAZYR 59 Orphan Drug designation 59 Toctino R 59 CE Marked 59 Clinical Trial Application 59 Icatibant 58 orphan designation 58 European Medicines Evaluation 58 Swissmedic 58 Orphan Drug 58 Orphan Drug status 57 Medicinal Products EMEA 57 BEMA Fentanyl 57 FDA Orphan Drug 57 Pivotal Phase III 57 Abstral 57 FDA Accepts 57 Mutual Recognition Procedure 57 NOXAFIL 56 Orphan Drug Status 56 received CE Marking 56 Telavancin 56 Positive Opinion 56 Augment Bone Graft 56 Ceftobiprole 56 injection USP 56 diabetic peripheral neuropathic pain 56 Surgical Adhesive 56 Toctino ® 55 Clevudine 55 Nexavar ® 55 Rotarix R 55 REVLIMID lenalidomide 55 Investigational Device Exemption 55 Sancuso 55 dalbavancin 55 Panzem R 55 Oncology Drug 55 ELAPRASE 55 DC Bead 55 NEBIDO 55 submitted Marketing Authorization 55 Oral Solution 55 R sorafenib tablets 55 alvimopan 55 apaziquone 55 Onsolis 54 Nimotuzumab 54 orphan medicinal product 54 pancreatic enzyme 54 submitted Biologics License 54 Pennsaid R 54 VPRIV 54 Phase III Clinical Trial 54 alitretinoin 54 Afluria 54 Receives CE 54 Therapeutic Goods Administration 54 Vitaros 54 Amrubicin 54 daptomycin 54 Torisel 54 Marketing Authorization Application MAA 54 ISTODAX 54 silodosin 54 taliglucerase alfa 53 Generic Version 53 Rebif ® 53 OTCQX RHHBY 53 direct thrombin inhibitor 53 MHLW 53 NeutroSpec 53 Pulmonary Arterial Hypertension 53 Pirfenidone 53 pseudobulbar affect PBA 53 Octreotide 53 Cimzia ® 53 Exalgo 53 SFDA approval 53 relapsing multiple sclerosis 53 ROTATEQ 53 Alvesco 53 LIALDA 53 USFDA approval 53 Hycamtin 53 ATryn ® 53 diabetic neuropathic pain 53 Extended Release Tablets 53 alogliptin 53 febuxostat 53 Relistor 53 THELIN 53 Urocidin 53 Extavia 53 Marketing Authorization Application 53 Drug Administration USFDA 53 Humanitarian Device Exemption